Literature DB >> 29794814

Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation.

Jun Sik Yoon1, Yu Rim Lee1, Young-Oh Kweon1, Won Young Tak1, Se Young Jang1, Soo Young Park1, Keun Hur2, Jung Gil Park3, Hye Won Lee4, Jae Min Chun5, Young Seok Han5, Won Kee Lee6.   

Abstract

BACKGROUND: To compare the clinical value of acoustic radiation force impulse (ARFI) elastography and transient elastography (TE) for hepatocellular carcinoma (HCC) recurrence prediction after radiofrequency ablation (RFA) and to investigate other predictors of HCC recurrence. PATIENTS AND METHODS: Between 2011 and 2016, 130 patients with HCC who underwent ARFI elastography and TE within 6 months before curative RFA were prospectively enrolled. Independent predictors of HCC recurrence were analyzed separately using ARFI elastography and TE. ARFI elastography and TE accuracy to predict HCC recurrence was determined by receiver operating characteristic curve analysis.
RESULTS: Of all included patients (91 men; mean age, 63.5 years; range: 43-84 years), 51 (42.5%) experienced HCC recurrence during the follow-up period (median, 21.9 months). In multivariable analysis using ARFI velocity, serum albumin and ARFI velocity [hazard ratios: 2.873; 95% confidence interval (CI): 1.806-4.571; P<0.001] were independent predictors of recurrence, and in multivariable analysis using TE value, serum albumin and TE value (hazard ratios: 1.028; 95% CI: 1.013-1.043; P<0.001) were independent predictors of recurrence. The area under the receiver operating characteristic curve of ARFI elastography (0.821; 95% CI: 0.747-0.895) was not statistically different from that of TE (0.793; 95% CI: 0.712-0.874) for predicting HCC recurrence (P=0.827). The optimal ARFI velocity and TE cutoff values were 1.6 m/s and 14 kPa, respectively.
CONCLUSION: ARFI elastography and TE yield comparable predictors of HCC recurrence after RFA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29794814     DOI: 10.1097/MEG.0000000000001170

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma.

Authors:  Song Wang; Jingtao Liu; Hao Wu; Anna Jiang; Kun Zhao; Kun Yan; Wei Wu; Haibo Han; Yanhua Zhang; Wei Yang
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

2.  Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment.

Authors:  Tae Hyung Kim; Jung Mi Chang; Soon Ho Um; Heejung Jee; Yoo Ra Lee; Han Ah Lee; Sun Young Yim; Na Yeon Han; Jae Min Lee; Hyuk Soon Choi; Eun Sun Kim; Young-Dong Yu; Bora Keum; Min Ju Kim; Hyunggin An; Beom Jin Park; Yeon Seok Seo; Dong-Sik Kim; Hyung Joon Yim; Sung Bum Cho; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Yun Hwan Kim; Chang Duck Kim
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation.

Authors:  Pei-Chang Lee; Yi-You Chiou; Nai-Chi Chiu; Ping-Hsien Chen; Chien-An Liu; Wei-Yu Kao; Teh-Ia Huo; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin; Jaw-Ching Wu; Chien-Wei Su
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.